It has been also reported that PAX2 is activated by E2 via ERα in breast cancer and it is confirmed that the expression of PAX2 is proportional to the expression of ERα in ovarian serous cancer [79]. Here, PAX2 is linked to ovarian serous adenocarcinoma.